These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 187278

  • 1. Vaccination against EB virus.
    Br Med J; 1976 Dec 18; 2(6050):1467-8. PubMed ID: 187278
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Implications of a vaccine for the prevention of Epstein-Barr virus infection: ethical and logistic considerations.
    Epstein MA.
    Cancer Res; 1976 Feb 18; 36(2 pt 2):711-4. PubMed ID: 175931
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
    Epstein MA, Morgan AJ.
    Clin Exp Immunol; 1983 Aug 18; 53(2):257-71. PubMed ID: 6309441
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The 1986 Walter Hubert lecture. Recent studies on a vaccine to prevent EB virus-associated cancers.
    Epstein MA.
    Br J Cancer; 1986 Jul 18; 54(1):1-5. PubMed ID: 3015179
    [Abstract] [Full Text] [Related]

  • 10. Approaches to immunological control of virus-associated tumors in man: introductory remarks.
    Levine PH.
    Cancer Res; 1976 Feb 18; 36(2 pt 2):565-9. PubMed ID: 175916
    [No Abstract] [Full Text] [Related]

  • 11. Immunologic markers for Epstein-Barr virus in the control of nasopharyngeal carcinoma and Burkitt lymphoma.
    Levine PH.
    Cancer Detect Prev Suppl; 1987 Feb 18; 1():217-23. PubMed ID: 2826001
    [Abstract] [Full Text] [Related]

  • 12. The Leeuwenhoek lecture, 1983. A prototype vaccine to prevent Epstein-Barr virus-associated tumours.
    Epstein MA.
    Proc R Soc Lond B Biol Sci; 1984 Mar 22; 221(1222):1-20. PubMed ID: 6144103
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cancer vaccine goes on trial.
    Practitioner; 1986 Apr 22; 230(1414):307-8. PubMed ID: 3090538
    [No Abstract] [Full Text] [Related]

  • 15. A prototype vaccine to prevent Epstein-Barr virus-associated cancers.
    Epstein M.
    Chemioterapia; 1987 Jun 22; 6(2 Suppl):655-8. PubMed ID: 2855615
    [No Abstract] [Full Text] [Related]

  • 16. Issues related to development of Epstein-Barr virus vaccines.
    Spring SB, Hascall G, Gruber J.
    J Natl Cancer Inst; 1996 Oct 16; 88(20):1436-41. PubMed ID: 8841018
    [No Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus behavior in different populations and implications for control of Epstein-Barr virus-associated tumors.
    de-Thé G.
    Cancer Res; 1976 Feb 16; 36(2 pt 2):692-5. PubMed ID: 1253156
    [Abstract] [Full Text] [Related]

  • 18. Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cottontop tamarins against EB virus-induced malignant lymphomas.
    Morgan AJ, Mackett M, Finerty S, Arrand JR, Scullion FT, Epstein MA.
    J Med Virol; 1988 Jun 16; 25(2):189-95. PubMed ID: 2839612
    [Abstract] [Full Text] [Related]

  • 19. What we could do with an EBV vaccine.
    Lancet; 1981 Apr 04; 1(8223):759-61. PubMed ID: 6110958
    [No Abstract] [Full Text] [Related]

  • 20. [Epstein-Barr virus and human cancer].
    Quattrocchi C, Signorile PG.
    Recenti Prog Med; 1980 May 04; 68(5):504-42. PubMed ID: 6256832
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.